MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
about
MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinomaInteractions between the Nse3 and Nse4 components of the SMC5-6 complex identify evolutionarily conserved interactions between MAGE and EID FamiliesMAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agentsMageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBsReciprocal roles of SIRT1 and SKIP in the regulation of RAR activity: implication in the retinoic acid-induced neuronal differentiation of P19 cellsCancer/testis antigens, gametogenesis and cancerCoordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancerFunctional interaction between co-expressed MAGE-A proteinsExpression of cancer-testis (CT) antigens in placenta.Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracksRas induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complexMAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4The role of MAGEA2 in head and neck cancer.Frequent expression of MAGE1 tumor antigens in bronchial epithelium of smokers without lung cancer.Cancer testis antigens--their importance in immunotherapy and in the early detection of cancer.Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines.Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer.Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.The biology of cancer testis antigens: putative function, regulation and therapeutic potentialSperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond.Cancer testes antigens in breast cancer: biological role, regulation, and therapeutic applicability.Cancer testis antigens: a novel target in lung cancer.Germ cell proteins in melanoma: prognosis, diagnosis, treatment, and theories on expression.Cancer-testis antigens and immunotherapy in the light of cancer complexity.Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes.Expression of cancer/testis antigens in prostate cancer is associated with disease progression.Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic StressMAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growth.Cancer-testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non-uterine leiomyosarcoma.MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific regulators.Cancer testis antigen expression in testicular germ cell tumorigenesis.Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs
P2860
Q21134039-EDDB4A1F-1900-4E31-B4AC-E6BB9535E9F3Q24294572-7375BE2E-452F-4CE2-A7F1-12226060420CQ24297439-8857D51F-1FF7-4668-9750-CE9F5C18302FQ24298306-4BE691CA-B031-45F2-A4B0-CEA8F8331218Q24320197-4406272B-09A7-4AB8-9B93-46828402F488Q29616129-EFB96A34-660B-4540-A390-838FEE38D09FQ33420388-EB757DED-C72B-43ED-BEF7-3817F70B94ACQ33725090-2FA5E9AF-0374-47D9-8AB5-B5008708C362Q34111764-7210E4AF-C83C-4703-90A4-78335B91CCF5Q35116913-157923BE-B910-43BE-953B-E9396EEB89E0Q35226147-1764D563-4673-40DF-8BE1-9BBBCEB511CFQ35543268-BF81EEB6-C6CD-4271-A7E5-A9B6404D483FQ35637193-79416257-D709-48D3-9963-0680475BE2A4Q35844503-47731A3A-4A93-4CD0-95ED-686B0CED2FA3Q36230469-C3D679CA-7183-4598-88BB-564FECA62EF0Q36425935-B79E2FA1-09A8-47DC-A6E0-B3BA313E23D0Q36614408-AEE3F085-1DA1-4664-AD78-D757876A5E1EQ36637039-187C3A15-7943-4A5B-9CEA-54F837CE290CQ36983356-22E8B7F6-DF61-4488-81E2-DE2031226EFEQ37700791-17E7D3AC-C4D4-4016-B3A8-8BF59F9F5E08Q37737327-B6C62ABA-6CB5-4FF7-BC7A-367ABB12317BQ37849976-70252EC0-47B6-4B50-A3F7-2BD96E308975Q37873931-DC1394D9-1880-4B3E-90A1-CD6D92383DB8Q38053488-6EBA9C10-2507-43FF-AA62-7ECF83F4F074Q38053489-4EA57F53-8A79-408D-864F-E10362F286B5Q38064856-FCDD004B-A264-4B6C-87DE-6F7A7401BEAAQ38435410-D95EB687-696F-4CDE-8AF1-D2074162A282Q39352950-F40A996D-2354-4983-B052-3F22C8C62A53Q39687648-CC1FBEE3-56F8-4A6A-A7D3-FC2D71B44073Q40430454-52B3F2DE-AFCF-4E60-9139-727DFB5F7B0CQ49278213-2A93E739-A424-40F4-BA53-7B445E8A89A2Q49335269-9DAC1FF4-3CCE-4458-914B-C90716EBACE5Q51026297-35184EFE-0B5F-43E9-AD75-575529BAA9DBQ53306166-971C87D6-D0AE-4118-933F-850F23CC269EQ54598067-78EC5858-47F7-46FA-846F-BAB9E0DB96D7Q58763204-2D34349A-4BD2-4EE4-A949-967593DDF547
P2860
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@ast
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@en
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@en-gb
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@nl
type
label
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@ast
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@en
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@en-gb
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@nl
prefLabel
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@ast
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@en
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@en-gb
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@nl
P2093
P2860
P356
P1476
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
@en
P2093
Charles De Smet
Danièle Godelaine
Etienne De Plaen
François Fuks
Olga Kholmanskikh
Rachel Deplus
S Diane Hayward
Sandra Laduron
Sifang Zhou
Thierry Boon
P2860
P304
P356
10.1093/NAR/GKH735
P407
P577
2004-01-01T00:00:00Z